BioSpace Senior Editor Annalee Armstrong headed to the J.P. Morgan Healthcare Conference with a months-long story idea ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Over two-thirds of the top 20 global firms reported a decline in market capitalisation. The biopharmaceutical industry showed ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

AI-related deals in the pharmaceutical sector grew by 14% compared to the same period in 2023. This year, AI is expected to ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

The biopharma industry is highly dynamic and competitive. Companies that succeed in it must be able to tackle various aspects, including finances, marketing, regulations, investor relations, ...

Major employers and innovators recognised at ceremony showcasing Ireland’s pharmaceutical leadership, as sector marks record ...